Japan Market Report: Antibody Purification and the Protein A Resin Supply Gap
We have published a new market report on BioMarket.jp, our Japanese life science portal: Antibody Drug Purification Support Market: Protein A Resin Supply Shortages and Opportunities for New Entrants (in Japanese). Here is an overview.
Overview
Upstream cell culture productivity for antibody drugs has improved greatly over the past decade. As a result, downstream purification now does most to decide manufacturing cost, quality and supply stability, and protein A affinity chromatography sits at its core.
Drawing on public information, the report maps the antibody purification market around protein A resin (market structure, technology trends, key players and business opportunities) for companies considering entry or expansion.
Growth drivers
- More biosimilar approvals
- Expanding CDMO and CRO manufacturing capacity
- Next-generation modalities such as bispecific antibodies, ADCs, AAV gene therapy and mRNA drugs
What the report covers
- Market overview, with size estimates for chromatography resins and protein A resin
- Trends by region and end user
- The purification workflow and how protein A resins are evolving
- Resin selection (alkali resistance and lifetime) and process economics measured as cost per gram
- Competitive landscape and the rise of prepacked columns
- Japan's wave of CDMO investment and dual-sourcing strategies
- Entry barriers: switching costs and regulatory filings (DMF/MF)
- Four opportunity areas for new entrants: second-source supply, prepacked column capability, modality-specific affinity ligands, and domestic supply with early DMF filing
The full report is available to BioMarket.jp members (free registration).
▶ Read the report on BioMarket.jp (in Japanese)
Researching this market in Japan
Public data says little about what Japanese researchers and manufacturers actually need and how they buy. BioSurvey asks Japanese life science researchers directly, so you can test demand and positioning before you commit. Contact us to discuss a study.